Melchior C. Nierman

Intramuscular Administration of AAV1-Lipoprotein Lipase ^S447X Lowers Triglycerides in Lipoprotein Lipase–Deficient Patients

Erik S.G. Stroes, Melchior C. Nierman, J. J. M. Meulenberg et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2008 · 207 citations · Full text

Translational Medicine, Lipid Disorder, Cardiovascular Disease +7

Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

Linda P.T. Joosten, Sander van Doorn, Peter M. van de Ven et al. · Circulation · 2023 · 156 citations · Full text

Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

Pythia T. Nieuwkerk, Melchior C. Nierman, Maud N. Vissers et al. · The American Journal of Cardiology · 2012 · 85 citations

Non-pharmacological Intervention, Hypertension, Preventive Medicine +11

Serum Lipoprotein Lipase Concentration and Risk for Future Coronary Artery Disease

Jaap Rip, Melchior C. Nierman, Nicholas J. Wareham et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 67 citations

Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application

Jaap Rip, Melchior C. Nierman, Jeroen A. Sierts et al. · Human Gene Therapy · 2005 · 62 citations

Lipoprotein Lipase, Engineering, In Vivo Gene Therapy +18